TipRanks
Arovella Therapeutics Limited (DE:E4NA)
FRANKFURT:E4NA
Germany Market
E4NA
Arovella Therapeutics Limited
RESEARCH TOOLSreports

Arovella Therapeutics Limited (E4NA) Income Statement

0 Followers

Arovella Therapeutics Limited Income Statement

Last quarter (Q4 2026), Arovella Therapeutics Limited's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was AU$-5.04M. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 136.00KAU$ 17.00KAU$ 405.90KAU$ 295.81K
Gross Profit
AU$ -117.71KAU$ 136.00KAU$ -25.98KAU$ -3.00MAU$ 88.75K
Operating Expenses
AU$ 11.10MAU$ 11.34MAU$ 10.79MAU$ 6.68MAU$ 5.23M
Depreciation and Amortization
AU$ 117.71KAU$ 107.29KAU$ 42.98KAU$ 837.18KAU$ 551.49K
EBITDA
AU$ -11.10MAU$ -11.10MAU$ -10.63MAU$ -10.37MAU$ -7.87M
Operating Income
AU$ -11.21MAU$ -11.20MAU$ -10.81MAU$ -9.68MAU$ -7.59M
Other Income/Expenses
AU$ 800.03KAU$ 3.69MAU$ 2.07MAU$ -1.55MAU$ -1.02M
Pretax Income
AU$ -10.41MAU$ -7.51MAU$ -8.75MAU$ -11.23MAU$ -8.62M
Net Income
AU$ -6.92MAU$ -7.51MAU$ -8.75MAU$ -10.18MAU$ -8.62M
Per Share Metrics
Basic EPS
AU$ >-0.01AU$ >-0.01AU$ -0.01AU$ -0.01AU$ -0.02
Diluted EPS
AU$ >-0.01AU$ >-0.01AU$ -0.01AU$ -0.01AU$ -0.02
Weighted Average Shares Outstanding
 1.20B 1.10B 941.42M 711.48M 549.62M
Weighted Average Shares Outstanding (Diluted)
 1.20B 1.10B 941.42M 711.48M 549.62M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History